Clinical Trial Update: Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating corticosteroids and anti-TNF therapy in methotrexate-inadequate responder patients with rheumatoid arthritis; current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Anti-TNF-α (TNF-alpha inhibitor)
• Corticosteroids (corticosteroids)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: RHEUMATOID ARTHRITIS | Phase 3 | Status: UNKNOWN